Praxis Precision Medicines, Inc. PRAX Total debt

Total debt at other companies

Jazz PharmaceuticalsJAZZ

$5.4B-0.1%

Xenon PharmaceuticalsXENE

$6.42M-26.4%

Stoke Therapeutics, Inc.STOK

$3.42M-42.5%

Rapport Therapeutics, Inc.RAPP

$10.11M-14.8%

Neurocrine BiosciencesNBIX

$463.5M-6.0%

BiogenBIIB

$7.56B+14.6%

FAQ

What is Praxis Precision Medicines, Inc.'s total debt?

Praxis Precision Medicines, Inc. (PRAX) reported total debt of $1.09M in Q2 2026.

How has Praxis Precision Medicines, Inc.'s total debt changed year-over-year?

Praxis Precision Medicines, Inc.'s total debt increased by 44.0% year-over-year, from $755K to $1.09M.

What is the long-term trend for Praxis Precision Medicines, Inc.'s total debt?

Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s total debt has grown at a -32.1% compound annual growth rate (CAGR), from $763K to $110K.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.